These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 11682262)
21. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats. Kotlinska JH; Gibula-Bruzda E; Koltunowska D; Raoof H; Suder P; Silberring J Peptides; 2012 Jan; 33(1):156-63. PubMed ID: 22197492 [TBL] [Abstract][Full Text] [Related]
22. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats. Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034 [TBL] [Abstract][Full Text] [Related]
23. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning. Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991 [TBL] [Abstract][Full Text] [Related]
24. An activity indicator of acute withdrawal depends on amphetamine dose in rats. White W; White IM Physiol Behav; 2006 Feb; 87(2):368-76. PubMed ID: 16364380 [TBL] [Abstract][Full Text] [Related]
25. An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats. Alderson HL; Latimer MP; Blaha CD; Phillips AG; Winn P Neuroscience; 2004; 125(2):349-58. PubMed ID: 15062978 [TBL] [Abstract][Full Text] [Related]
26. Responding for brain stimulation reward in the bed nucleus of the stria terminalis in alcohol-preferring rats following alcohol and amphetamine pretreatments. Eiler WJ; Hardy L; Goergen J; Seyoum R; Mensah-Zoe B; June HL Synapse; 2007 Nov; 61(11):912-24. PubMed ID: 17701965 [TBL] [Abstract][Full Text] [Related]
27. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats. Barr AM; Zis AP; Phillips AG Psychopharmacology (Berl); 2002 Jan; 159(2):196-202. PubMed ID: 11862349 [TBL] [Abstract][Full Text] [Related]
28. Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat. Barr AM; Fiorino DF; Phillips AG Pharmacol Biochem Behav; 1999 Nov; 64(3):597-604. PubMed ID: 10548277 [TBL] [Abstract][Full Text] [Related]
29. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats. Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349 [TBL] [Abstract][Full Text] [Related]
30. Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine. Semenova S; Markou A Biol Psychiatry; 2003 Dec; 54(11):1249-64. PubMed ID: 14643093 [TBL] [Abstract][Full Text] [Related]
31. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline. Buccafusco JJ; Bain JN Neuroscience; 2007 Nov; 149(3):487-98. PubMed ID: 17916413 [TBL] [Abstract][Full Text] [Related]
32. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens. Vacca G; Ahn S; Phillips AG Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats. Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695 [TBL] [Abstract][Full Text] [Related]
34. Glucose intolerance induced by oligemic brain hypoxia: the effect of terguride. Golda V; Hilgertová J Acta Medica (Hradec Kralove); 1997; 40(3):57-60. PubMed ID: 9465428 [TBL] [Abstract][Full Text] [Related]
35. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Paterson NE; Myers C; Markou A Psychopharmacology (Berl); 2000 Nov; 152(4):440-6. PubMed ID: 11140337 [TBL] [Abstract][Full Text] [Related]
36. A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole. Makhinson M; Gomez-Makhinson J Am J Addict; 2014; 23(5):475-7. PubMed ID: 24628996 [TBL] [Abstract][Full Text] [Related]
37. Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions. Schindler CW; Persico AM; Uhl GR; Goldberg SR Pharmacol Biochem Behav; 1994 Sep; 49(1):41-6. PubMed ID: 7816888 [TBL] [Abstract][Full Text] [Related]
38. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. Gillin JC; Pulvirenti L; Withers N; Golshan S; Koob G Biol Psychiatry; 1994 Jun; 35(11):843-9. PubMed ID: 8054406 [TBL] [Abstract][Full Text] [Related]
39. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment. Srisurapanont M; Jarusuraisin N; Jittiwutikan J Aust N Z J Psychiatry; 1999 Feb; 33(1):94-8. PubMed ID: 10197891 [TBL] [Abstract][Full Text] [Related]